Back
BioLineRx Ltd. Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
22
BLRX
BioLineRx Ltd.
Last Price:
$3.26
Seasonality Move:
-3.99%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.
BioLineRx Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.37 | Sell |
| 20-day SMA: | 3.36 | Sell |
| 50-day SMA: | 3.62 | Sell |
| 200-day SMA: | 3.72 | Sell |
| 8-day EMA: | 3.31 | Sell |
| 20-day EMA: | 3.38 | Sell |
| 50-day EMA: | 3.55 | Sell |
| 200-day EMA: | 5.86 | Sell |
BioLineRx Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 43.68 | Sell |
| Chaikin Money Flow: | -5778 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.27 - 3.47) | Sell |
| Bollinger Bands (100): | (3.44 - 4.1) | Sell |
BioLineRx Ltd. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioLineRx Ltd. Stock
Is BioLineRx Ltd. Stock a Buy?
-
BioLineRx Ltd. share price is 3.26 while BLRX 8-day simple moving average is 3.37, which is a Sell signal.
-
The stock price of BLRX is 3.26 while BioLineRx Ltd. 20-day SMA is 3.36, which makes it a Sell.
-
BioLineRx Ltd. 50-day simple moving average is 3.62 while BLRX share price is 3.26, making it a Sell technically.
-
BLRX stock price is 3.26 and BioLineRx Ltd. 200-day simple moving average is 3.72, creating a Sell signal.
BLRX Technical Analysis vs Fundamental Analysis
Sell
22
BioLineRx Ltd. (BLRX)
is a Sell
Is BioLineRx Ltd. a Buy or a Sell?
-
BioLineRx Ltd. stock is rated a SellThe current BioLineRx Ltd. [BLRX] share price is $3.26. The Score for BLRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
BioLineRx Ltd. Stock Info
Market Cap:
14.2M
Price in USD:
3.26
Share Volume:
14.4K
BioLineRx Ltd. 52-Week Range
52-Week High:
14.70
52-Week Low:
2.30
Sell
22
BioLineRx Ltd. (BLRX)
is a Sell
BioLineRx Ltd. Share Price Forecast
-
What is the BioLineRx Ltd. stock price today?The BioLineRx Ltd. stock price is 3.26 USD today.
-
Will BLRX stock go up or go down?BioLineRx Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioLineRx Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioLineRx Ltd. is overvalued.
Is BioLineRx Ltd. Stock a Buy?
-
BioLineRx Ltd. share price is 3.26 while BLRX 8-day exponential moving average is 3.31, which is a Sell signal.
-
The stock price of BLRX is 3.26 while BioLineRx Ltd. 20-day EMA is 3.38, which makes it a Sell.
-
BioLineRx Ltd. 50-day exponential moving average is 3.55 while BLRX share price is 3.26, making it a Sell technically.
-
BLRX stock price is 3.26 and BioLineRx Ltd. 200-day simple moving average is 5.86, creating a Sell signal.
Fundamental Analysis of BioLineRx Ltd.
Is BioLineRx Ltd. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.52 per share, and a decrease next year of $0.23 per share.
Technical Analysis of BioLineRx Ltd.
Should I short BioLineRx Ltd. stock?
-
BLRX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting BioLineRx Ltd. is a Sell
-
BioLineRx Ltd. Relative Strength Index (RSI) is 43.68, which suggest BioLineRx Ltd. is oversold
-
The Bollinger Bands (25) for BioLineRx Ltd. is (3.27 - 3.47), which suggest BioLineRx Ltd. is a Sell
-
The Bollinger Bands (100) for BioLineRx Ltd. is (3.44 - 4.1), which suggest BioLineRx Ltd. is a Sell
* BioLineRx Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.